Company intelligence / Profile preview

Oui Therapeutics

New Haven, Connecticut, United Statesouitherapeutics.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Oui Therapeutics has developed what it describes as the world’s first prescription digital therapeutic specifically for suicide prevention. The company’s lead product, OTX‑202, aims to reduce suicides and suicide attempts. Clinical trials are currently underway with published studies showing dramatic reductions in suicide attempts using their interventions. The company has been featured for conducting the first-ever randomized clinical trial using telehealth for suicide prevention.

Therapeutic areas: Psychiatry
Modalities: Digital therapeutics (software-based interventions)
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

PEX010

Phase 2

Indications: Adjustment disorder in palliative care

Partnerships

Strategic partners include leading digital therapy experts and payer ecosystem stakeholders; specific companies or institutions not named publicly.

Beyond the preview

Go deeper on Oui Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oui Therapeutics.

Explore the full profile